.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Rite Aid Sees Advantage in Buying an Established PBM

Published on: February 12, 2015

The New York Times reported today that the drug store chain Rite Aid will buy Envision Pharmaceutical Services, a pharmacy benefit manager, for $2 billion.

Rite Aid, the big pharmacy chain, agreed on Wednesday to acquire a top pharmacy benefit manager, Envision Pharmaceutical Services, for $2 billion in cash and stock .

Envision Pharmaceutical Services, known as EnvisionRx, is owned by the private equity firm TPG, making this one of the year’s early successful exits for a buyout firm.

Rite Aid will pay TPG about $1.8 billion in cash and $200 million in stock for EnvisionRx. The value of the deal also includes an expected future tax benefit of $275 million.

Complete report on The New York Times:

http://nyti.ms/1A0g8TS